Crossmark

Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy

Crossref DOI link: https://doi.org/10.1186/s12886-023-03092-z

Published Online: 2023-07-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alvarado-Castillo, Beatriz

Santa Cruz-Pavlovich, Francisco J.

Gonzalez-Castillo, Celia

Vidal-Paredes, Isaac Alejandro

Garcia-Benavides, Leonel

Rosales-Gradilla, Maria Elena

Navarro-Partida, Jose
License Information

Text and Data Mining valid from 2023-07-27

Version of Record valid from 2023-07-27
More Information

Article History

Received: 18 November 2022

Accepted: 20 July 2023

First Online: 27 July 2023

Declarations

:

: Ethics Committee approval from the Instituto Mexicano del Seguro Social (IMSS), Centro Medico Nacional de Occidente, was obtained (IMSS Register Number R-2012-785-094). Written informed consent was obtained from all subjects before enrollment. All procedures related to the implementation of this study were supported in the tenets of the Declaration of Helsinki.

: Not applicable.

: The authors have no competing interests to declare.

Document is current

Any future updates will be listed below